Icagen drug fails in trial; shares plummet

Full story: Triangle Business Journal

Shares of Icagen Inc. plunged Tuesday on news that the Research Triangle Park-based company plans to stop development of senicapoc due to the asthma drug's failure in a clinical trial.

Post

Leave a Comment

Email me Asthma news. Learn more

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Asthma Discussions

Topic	Updated	Last By	Comments
Tough to breathe, is it wood smoke?	Feb 4	WhoOwnsTheAir	149
Advair beats Spiriva in treatment of COPD (Dec '07)	Feb 4	John	43
Primatene Mist May Be Pulled From Market (Jan '06)	Feb 2	The 8man	255
Pycnogenol Benefits Asthma	Jan 30	PycnogenolBenefits	1
Tell me, why do I have asthma?	Jan 28	Greg Baker	3
1 Joint Equals Up to 5 Cigarettes - (Aug '07)	Jan 21	ipouono	40
Rawatan Khusus Asthma/Lelah	Jan 13	Adzhar Shaharin	1